• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Periprocedural anticoagulation: Heparin bridging therapy associated with increased risk of bleeding

bys25qthea
September 26, 2012
in Cardiology, Neurology, Surgery
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]

Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers

APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact

Image: CC

Key study points:

1.    Patients on long-term warfarin who undergo periprocedural bridging with heparin have a >5x increased risk of overall bleeding and >3x increased risk of major bleeding compared with non-bridged or non-anticoagulated comparators.

2.    The risk of thromboembolic events is similar in both bridged and non-bridged groups.
 

Primer: Managing periprocedural anticoagulation in patients on long-term warfarin is a common clinical problem.  If anticoagulation is interrupted before an invasive procedure, patients bear an increased risk of thromboembolic events.  If anticoagulation is continued, patients risk the possibility of bleeding events.  Thus the risk of periprocedural bleeding must be weighed against the risk of thrombosis.  While validated risk stratification scores (HAS-BLED) exist for this purpose in conditions like atrial fibrillation, the management of anticoagulation before interventional procedures remains controversially empirical.  The widely employed empiric approach involves discontinuing warfarin but continuing anticoagulation with a heparin bridge, the rationale being replacement of a long-acting agent with one that is short-acting and easily reversible means anticoagulation can be stopped soon before and resumed soon after a procedure.  Although the strategy is appealingly elegant, it has yet to be backed by sound evidence.

 

This [systematic review and meta-analysis] by Siegal et al comprises 34 studies (including 1 randomized trial) of periprocedural bridging with low-molecular-weight-heparin (LMWH), representing altogether > 12,000 patients.  The authors established a baseline risk of periprocedural bleeding and thromboembolism using control groups comprising warfarin users with low-thromboembolic risk who remained unbridged or patients not on warfarin.

Using standard meta-analysis methods, bridging therapy was found to be associated with a  >5x increased risk of overall bleeds (odds ratio, 5.40; 95% CI, 3.00–9.74) and >3x increased risk of major bleeds (odds ratio, 3.60; 95% CI, 1.52–8.50).  Bridged and non-bridged patients had similar rates of thromboembolic events (odds ratio, 0.80; 95% CI, 0.42–1.54).

A comparison of therapeutic vs. prophylactic/intermediate doses of LMWH revealed an increased risk of overall bleeds with the therapeutic dose.  In studies with subgroup analyses based on procedural risk, bleeding rates were highest in bridged patients undergoing procedures with a high-bleeding risk. 

In sum: These results call into question the widely prevalent practice of periprocedural bridging of warfarin with LMWH.  The authors conclude that long-term warfarin users should avoid the customary periprocedural LMWH bridge, especially one at a therapeutic dose, especially if they have a less-than-high thromboembolic risk and especially if they are undergoing a high-bleeding-risk procedure. 

This study represents the largest collection of data on periprocedural management of warfarin patients with heparin.  Besides the limitations intrinsic to meta-analyses, one limitation of this study is the heterogeneity of data mirroring variations in clinical practice.  For example, these studies coalesce multiple bridging regimes with varying doses and multiple procedures with varying bleeding risk. Moreover, the definitions of bleeding events and thromboembolic events vary among studies.  Last, the indications for anticoagulation and definitions of high-risk for bleeding / thromboembolism vary among studies, so it remains unclear how the baseline risk of events affects the actual outcomes. 

Ongoing randomized trials (PERIOP-2, BRIDGE, and BRUISECONTROL) may address these limitations, but until then, this study remains the best summary of existing evidence on periprocedural bridging therapy.

Click to read the study in Circulation

More background reading:

1. Guyatt GH et al. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:7S-47S
2. Wysokinski WE and McBane RD. Periprocedural bridging management of anticoagulation. Circulation. 2012;126:486-490
3. Douketis JD. Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery.” Thromb Haemost. 2012;108:210-212.
4. Spyropoulus AC. Pro: ““Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery.” Thromb Haemost. 2012;108:213-216.


Written by MP

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

 

Previous Post

Four different types of breast cancer revealed based on molecular data

Next Post

CT angiography and non-invasive fractional flow reserve have improved diagnostic accuracy for coronary obstructions

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]

July 2, 2022
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers

July 1, 2022
Few differences in location-stratified football-related concussions
Chronic Disease

APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact

July 1, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]

July 1, 2022
Next Post

CT angiography and non-invasive fractional flow reserve have improved diagnostic accuracy for coronary obstructions

Hospital procedure volume should not be used as a measure of surgical quality

Gastric bypass surgery for the severely obese associated with higher diabetes remission versus nonsurgical controls

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.